Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionality is currently unavailable.

Melvin Eugene Clouse, M.D.

Co-Author

This page shows the publications co-authored by Melvin Clouse and Jonathan Kruskal.
Connection Strength

0.925
  1. Kruskal JB, Lunderquist A, Clouse ME. Halothane-induced intrahepatic portovenous shunting reduces hepatic microvascular sinusoidal perfusion during contrast angiographic procedures. J Vasc Interv Radiol. 1998 Mar-Apr; 9(2):311-20.
    View in: PubMed
    Score: 0.207
  2. Kruskal JB, Lunderquist A, Clouse ME. Hepatic in vivo video microscopic study for evaluating experimental and approved magnetic resonance contrast agents. Invest Radiol. 1994 Jun; 29 Suppl 2:S83-6.
    View in: PubMed
    Score: 0.160
  3. Kruskal JB, Hlatky L, Hahnfeldt P, Teramoto K, Stokes KR, Clouse ME. In vivo and in vitro analysis of the effectiveness of doxorubicin combined with temporary arterial occlusion in liver tumors. J Vasc Interv Radiol. 1993 Nov-Dec; 4(6):741-7.
    View in: PubMed
    Score: 0.153
  4. Goldberg SN, Stein MC, Gazelle GS, Sheiman RG, Kruskal JB, Clouse ME. Percutaneous radiofrequency tissue ablation: optimization of pulsed-radiofrequency technique to increase coagulation necrosis. J Vasc Interv Radiol. 1999 Jul-Aug; 10(7):907-16.
    View in: PubMed
    Score: 0.057
  5. Cay O, Kruskal JB, Nasser I, Thomas P, Clouse ME. Liver metastases from colorectal cancer: drug delivery with liposome-encapsulated doxorubicin. Radiology. 1997 Oct; 205(1):95-101.
    View in: PubMed
    Score: 0.050
  6. Cay O, Kruskal J, Thomas P, Clouse ME. Targeting of different ethiodized oil-doxorubicin mixtures to hypovascular hepatic metastases with intraarterial and intraportal injections. J Vasc Interv Radiol. 1996 May-Jun; 7(3):409-17.
    View in: PubMed
    Score: 0.046
  7. Roizental M, Kane RA, Takahashi J, Kruskal J, Crenshaw WB, Perry L, Stokes K, Clouse ME. Portal vein: US-guided localization prior to transjugular intrahepatic portosystemic shunt placement. Radiology. 1995 Sep; 196(3):868-70.
    View in: PubMed
    Score: 0.043
  8. Kawano K, Bowers JL, Kruskal JB, Clouse ME. In vivo microscopic assessment of hepatic microcirculation during liver allograft rejection in the rat. Transplantation. 1995 May 15; 59(9):1241-8.
    View in: PubMed
    Score: 0.043
  9. Teramoto K, Bowers JL, Kruskal JB, Hara J, Iwai T, Endo M, Clouse ME. In vivo microscopic observation of fatty liver grafts after reperfusion. Transplant Proc. 1994 Aug; 26(4):2391.
    View in: PubMed
    Score: 0.040
  10. Teramoto K, Bowers JL, Kruskal JB, Clouse ME. Hepatic microcirculatory changes after reperfusion in fatty and normal liver transplantation in the rat. Transplantation. 1993 Nov; 56(5):1076-82.
    View in: PubMed
    Score: 0.038
  11. Clouse ME, Stokes KR, Kruskal JB, Perry LJ, Stuart KE, Nasser IA. Chemoembolization for hepatocellular carcinoma: epinephrine followed by a doxorubicin-ethiodized oil emulsion and gelatin sponge powder. J Vasc Interv Radiol. 1993 Nov-Dec; 4(6):717-25.
    View in: PubMed
    Score: 0.038
  12. Bowers JL, Lanir A, Metz KR, Kruskal JB, Lee RG, Balschi J, Federman M, Khettry U, Clouse ME. 23Na- and 31P-NMR studies of perfused mouse liver during nitrogen hypoxia. Am J Physiol. 1992 Apr; 262(4 Pt 1):G636-44.
    View in: PubMed
    Score: 0.034
  13. Goldberg SN, Kruskal JB, Oliver BS, Clouse ME, Gazelle GS. Percutaneous tumor ablation: increased coagulation by combining radio-frequency ablation and ethanol instillation in a rat breast tumor model. Radiology. 2000 Dec; 217(3):827-31.
    View in: PubMed
    Score: 0.016
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.